UK drug early access scheme - interest grows but no submissions yet
This article was originally published in SRA
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency has yet to receive any applications from drug companies wishing to take part in the early access to medicines scheme (EAMS) that it launched around two months ago1.